The following is an excerpt.
A clinical trial for a Type 1 diabetes vaccine has resulted in promising findings, suggesting there may be a future where we can prevent people from getting the disease.
Researchers completed a 12-week trial on a DNA-based vaccine on 80 subjects with Type 1 diabetes. The patients were able to maintain levels of a blood-borne intermediary that can stimulate insulin production, and some subjects were able to increase levels. That suggests the cellular changes that occur in patients with Type 1 diabetes may be shut down.
Read the full story here: New Type 1 diabetes vaccine shows promising results
